It is able to inhibit the type 1 glycine transporter.

[1] This inhibition increases extracellular levels of glycine.

LY-2365109 has been shown to increase the seizure threshold in mice, meaning that this drug has potential as an anticonvulsant.

This article about an organic compound is a stub.

You can help Wikipedia by expanding it.This pharmacology-related article is a stub.